Open Access

[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway

  • Authors:
    • Quan Chen
    • Ping Li
    • Yong Xu
    • Yang Li
    • Bo Tang
  • View Affiliations

  • Published online on: February 20, 2023     https://doi.org/10.3892/or.2023.8505
  • Article Number: 68
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Oncol Rep 33: [Related article:] 840–848, 2015; DOI: 10.3892/or.2014.3626

Subsequent to the publication of the above article, a concerned reader drew to our attention that the flow cytometric plots shown in Fig. 2 had previously appeared in another article published in the journal Oncology Reports [Huang G, Tang B, Tang K, Dong X, Deng J, Liao L, Liao Z, Yang H and He S: Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway. Oncol Rep 31: 2377–2384, 2014], suggesting that data purportedly showing results obtained under different experimental conditions had been derived from the same original source.

Given the errors that were identified in the compilation of Fig. 2 in this article, and the fact that all the data in this figure had been re-used from a previously published source, the Editor of Oncology Reports has decided that this article should be retracted from the publication owing to a lack of overall confidence in the presented data. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a satisfactory reply. The Editor apologizes to the readership for any inconvenience that might result from the retraction of this article.

Related Articles

Journal Cover

April-2023
Volume 49 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen Q, Li P, Xu Y, Li Y and Tang B: [Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway. Oncol Rep 49: 68, 2023
APA
Chen, Q., Li, P., Xu, Y., Li, Y., & Tang, B. (2023). [Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway. Oncology Reports, 49, 68. https://doi.org/10.3892/or.2023.8505
MLA
Chen, Q., Li, P., Xu, Y., Li, Y., Tang, B."[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway". Oncology Reports 49.4 (2023): 68.
Chicago
Chen, Q., Li, P., Xu, Y., Li, Y., Tang, B."[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway". Oncology Reports 49, no. 4 (2023): 68. https://doi.org/10.3892/or.2023.8505